Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Ramos-Font

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Nuclear Medicine and Molecular Imaging|July 17, 2013
Comparative study of the safety of regadenoson between patients with mild/moderate chronic obstructive pulmonary disease and asthmaCarlos Salgado Garcia, Carlos Salgado Garcia, Amelia Jimenez Heffernan, et al.
Journal of Surgical Oncology|May 26, 2006
Application of modern imaging methods in diagnosis of gallbladder cancerAntonio Rodríguez-Fernández, Manuel Gómez-Río, Antonio Medina-Benítez, et al.
American Journal of Surgery|July 14, 2004
Positron-emission tomography with fluorine-18-fluoro-2-deoxy-D-glucose for gallbladder cancer diagnosisAntonio Rodríguez-Fernández, Manuel Gómez-Río, José Manuel Llamas-Elvira, et al.
BMC Complementary and Alternative Medicine|April 16, 2008
Study protocol for a pragmatic randomised controlled trial in general practice investigating the effectiveness of acupuncture against migraineJorge Vas, Angel Rebollo, Emilio Perea-Milla, et al.
Plos One|January 20, 2026
Correction: Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trialSergio Sequera-Arquelladas, María J Vivancos, David Vinuesa, et al.
Plos One|September 22, 2025
Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trialSergio Sequera-Arquelladas, María J Vivancos, David Vinuesa, et al.
International Journal of Antimicrobial Agents|April 4, 2024
Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trialCarmen Hidalgo-Tenorio, Sergio Sequera, María Jesus Vivancos, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Nuclear Medicine and Molecular Imaging|July 17, 2013
Comparative study of the safety of regadenoson between patients with mild/moderate chronic obstructive pulmonary disease and asthmaCarlos Salgado Garcia, Carlos Salgado Garcia, Amelia Jimenez Heffernan, et al.
Journal of Surgical Oncology|May 26, 2006
Application of modern imaging methods in diagnosis of gallbladder cancerAntonio Rodríguez-Fernández, Manuel Gómez-Río, Antonio Medina-Benítez, et al.
American Journal of Surgery|July 14, 2004
Positron-emission tomography with fluorine-18-fluoro-2-deoxy-D-glucose for gallbladder cancer diagnosisAntonio Rodríguez-Fernández, Manuel Gómez-Río, José Manuel Llamas-Elvira, et al.
BMC Complementary and Alternative Medicine|April 16, 2008
Study protocol for a pragmatic randomised controlled trial in general practice investigating the effectiveness of acupuncture against migraineJorge Vas, Angel Rebollo, Emilio Perea-Milla, et al.
Plos One|January 20, 2026
Correction: Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trialSergio Sequera-Arquelladas, María J Vivancos, David Vinuesa, et al.
Plos One|September 22, 2025
Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trialSergio Sequera-Arquelladas, María J Vivancos, David Vinuesa, et al.
International Journal of Antimicrobial Agents|April 4, 2024
Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trialCarmen Hidalgo-Tenorio, Sergio Sequera, María Jesus Vivancos, et al.
Pageof 2